Latest Shareholder Approvals News

Vinyl Group has secured a $1.5 million revolving credit facility from Songtradr and proposed converting historical liabilities into equity, aiming to boost its balance sheet and accelerate growth on its Vinyl.com platform.

Lodestar Minerals announces a $2.2 million two-tranche capital raising to advance its Chile exploration projects and evaluate new opportunities, signaling renewed investor confidence.

New World Resources and Central Asia Metals have agreed to increase their takeover offer to 6.2 cents per share, surpassing a competing bid and reshaping the acquisition landscape.

Butn Limited has locked in a $10 million corporate credit facility with Mighty Partners, providing non-dilutive capital to support its expanding receivables book and operational growth.

Peak Rare Earths has satisfied a critical Tanzanian mining licence condition and secured regulatory consent, advancing its proposed acquisition by a Shenghe subsidiary. The deal still awaits shareholder and further regulatory approvals.

GTN Limited is set to seek shareholder approval for a substantial $44 million capital return, aiming to reward investors without compromising its dividend policy.

GBM Resources has completed the first tranche of its capital raising, issuing nearly 245 million shares at $0.006 each, while the second tranche and additional securities await shareholder approval.

Andromeda Metals has launched a $5 million capital raising via a Placement, accompanied by Placement and Broker Options, to advance its flagship Great White Project and High Purity Alumina development.

Microba Life Sciences invites eligible shareholders to participate in a $2 million Share Purchase Plan at $0.09 per share, matching recent institutional pricing and including free attaching options. The capital raise aims to accelerate clinical adoption and push the company towards regional break-even.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.

Multistack International Limited is set to sell all assets and liabilities of its operating subsidiary to Super Link Company Limited, marking a strategic exit from its loss-making industrial cooling business. The company will retain a small net asset base while exploring new business opportunities.

Atomo Diagnostics has successfully closed a Share Purchase Plan and secured shareholder approval for a Tranche 2 Placement, raising a combined $1.53 million to support its ongoing operations.